For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240805:nRSE0688Za&default-theme=true
RNS Number : 0688Z Benchmark Holdings PLC 05 August 2024
5 August 2024
Benchmark Holdings plc
("Benchmark" or "the Company")
Notice of Q3 Results
Presentation for analysts and institutional investors
Equity Development webcast for retail investors
Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture
biotechnology business, will announce its Q3 results for the three month
period ended 30 June 2024, on Thursday 22(nd) August 2024.
Presentation for analysts and institutional investors at 08.00 UK time (09.00
CEST)
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a presentation for analysts and institutional investors on
the day at 08.00 UK time (09.00 CEST).
The presentation will be held in person at Haakon Vlls Gate 2, Oslo, Norway.
To register your interest, please contact benchmark@mhpgroup.com
A live webcast of the presentation will be available for analysts and
investors to join remotely at the following
link: https://channel.royalcast.com/landingpage/hegnarmedia/20240822_11/
(https://protect.checkpoint.com/v2/___https:/channel.royalcast.com/landingpage/hegnarmedia/20240822_11/___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzplZGE4OTQzOTZmMGU1OTgxNDk1MDkzOWE1YTAzMzdiNTo2OmEwZTM6ZTM5NGExMjdmYzhlMDk3YjU2MGI4ZmE0M2RkOGY4MjFiYWNlMGFhOTJkNDEzOTQ3NGEzOGU4NDY0NTYwMjY0MDpoOkY6Tg)
Equity Development webcast for retail investors at 12.00 UK time (13.00 CEST)
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a second webcast for retail investors and wealth managers at
12.00 UK time (13.00 CEST). The webcast is open to all existing and potential
shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-investor-presentation-22aug2024
(https://protect.checkpoint.com/v2/___https:/www.equitydevelopment.co.uk/news-and-events/benchmark-investor-presentation-22aug2024___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzozOWRjYmJlMDgyMDg5YjdiNzgyMjE5YjkxNjkyYTQ1NTo2OjRlNmU6YmM1ZmQ4NGE5YjQwNjE0ZTQ1NDBlYmMwYjU1YWFmYTI1YTEwNjc4N2I2MGE2MDI2NDVjNjhkM2VmNDJjZDZlYTpwOlQ6Tg)
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 0114 240 9939
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Deutsche Numis (Nominated Adviser and Broker) Tel: 020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare benchmark@mhpgroup.com
Equity Development Tel: 020 7065 2692
Hannah Crowe
About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission
is to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition
of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com
(https://protect.checkpoint.com/v2/___http:/www.benchmarkplc.com/___.bXQtcHJvZC1jcC1ldXcyLTE6bmV4dDE1OmM6bzozOWRjYmJlMDgyMDg5YjdiNzgyMjE5YjkxNjkyYTQ1NTo2OjgyMTc6M2ZlZmUzNzIwNGM5ZTVkZjJhZTY3YzVkNzU4OGJhYjQzODYxN2UwNDE4Nzk4NmExMzkzMDE4NzRhYzQwOWM0MDpwOlQ6Tg)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORUPUMWRUPCGRP